United States Patent and Trademark Office January 6, 2015 – Federal Register Recent Federal Regulation Documents
Results 1 - 1 of 1
Grant of Interim Extension of the Term of U.S. Patent No. 5,593,823; INTERCEPT® Blood System for Plasma
The United States Patent and Trademark Office has issued an order granting a second interim extension under 35 U.S.C. 156(d)(5) for a one-year interim extension of the term of U.S. Patent No. 5,593,823.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.